[Thymic hormone treatment of acute and chronic respiratory infections in the elderly]

Abstract

Respiratory infections are particularly frequent in aged subjects and cause severe and often inauspicious complications) such as compromised cell-mediated immunity. Preliminary data suggest thymopentin treatment in a population of elderly subjects affected by relapses of bronchial disease. The effects of the therapy are adequately monitored controlling immunologic parameters.